List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 2066 studies with search of:   United States, Utah
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Interventions: Drug: cyclophosphamide;   Drug: goserelin
2 Recruiting Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer;   Prostate Cancer
Interventions: Drug: placebo;   Drug: zoledronic acid
3 Completed Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
4 Active, not recruiting Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Drug: tipifarnib;   Procedure: radiation therapy
5 Recruiting Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: clodronate disodium;   Drug: ibandronate sodium;   Drug: zoledronic acid
6 Active, not recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: filgrastim;   Drug: paclitaxel;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
7 Active, not recruiting Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
Condition: Kidney Cancer
Intervention: Drug: erlotinib hydrochloride
8 Completed Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA
Condition: Rotavirus Gastroenteritis
Intervention: Biological: 2-dose oral live attenuated G1P[8] human rotavirus vaccine
9 Active, not recruiting Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: cisplatin;   Procedure: conventional surgery;   Procedure: radiation therapy
10 Active, not recruiting Urine and Blood Protein Levels in Predicting One-Year Recurrence of Glioblastoma Multiforme in Patients Undergoing Radiation Therapy
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: laboratory biomarker analysis;   Procedure: radiation therapy
11 Recruiting Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: capecitabine;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Procedure: conventional surgery
12 Recruiting A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Sunitinib + Capecitabine;   Drug: Capecitabine
13 Recruiting Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Conditions: Esophageal Cancer;   Gastric Cancer
Interventions: Drug: cisplatin;   Drug: epirubicin hydrochloride;   Drug: fluorouracil;   Drug: leucovorin calcium;   Procedure: radiation therapy
14 Recruiting Single-Fraction Radiation Therapy Compared With Multiple-Fraction Reirradiation Therapy in Treating Patients With Painful Bone Metastases
Conditions: Metastatic Cancer;   Pain
Interventions: Procedure: pain therapy;   Procedure: radiation therapy
15 Completed Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: rituximab;   Drug: yttrium Y 90 ibritumomab tiuxetan
16 Active, not recruiting Immunogenicity & Safety of GSK's Meningococcal Vaccine 134612 Given at 12-15 Months of Age or at 15-18 Months of Age
Condition: Invasive Neisseria Meningitidis Serogroup Diseases
Intervention: Biological: GSK vaccine 134612
17 Active, not recruiting Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Condition: Head and Neck Cancer
Interventions: Drug: cetuximab;   Drug: cisplatin;   Drug: docetaxel;   Procedure: adjuvant therapy;   Procedure: radiation therapy
18 Recruiting Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
Condition: Breast Cancer
Intervention: Procedure: chemotherapy
19 Active, not recruiting Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: placebo;   Drug: sorafenib tosylate
20 Recruiting Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: paclitaxel;   Drug: trastuzumab;   Procedure: radiation therapy

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services